HOME >> MEDICINE >> NEWS
USC professor at Childrens Hospital Los Angeles receives $2.5M for stem cell research

Los Angeles, Mar. 16, 2007 The California Institute for Regenerative Medicine (CIRM) has awarded $2.5 million to Gay M. Crooks, M.D., professor of pediatrics at the Keck School of Medicine of the University of Southern California (USC) and research-scientist at The Saban Research Institute of Childrens Hospital Los Angeles, for research in blood formation from stem cells.

The grant announced today is the latest award made to faculty building USC's new stem cell research program. Crooks' study, titled "Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC)," was highly recommended by CIRM for funding.

"The clinical potential of human embryonic stem cells for transplantation will be realized only when we can develop methods to control how mature cells are produced far more effectively than is currently the case," says Crooks. "As a pediatric bone marrow transplant physician, I am keenly aware of the profound clinical problems that my patients face. Matched stem cells from healthy donors are often not available and the immune system recovers poorly after transplantation."

According to Martin Pera, Ph.D., director of USC's Center for Stem Cell and Regenerative Medicine (CSCRM), USC stem cell scientists and Childrens Hospital Los Angeles faculty, who hold USC appointments, work closely with each other and in collaboration with Caltech to advance stem cell research. "As part of a unique tri-institutional program, we currently collaborate on a CIRM training program for new stem cell researchers. Additionally, Childrens Hospital Los Angeles faculty serve on the Steering Committee of USC's Center for Stem Cell and Regenerative Medicine." Pera is also a professor of cell and neurobiology at the Keck School of Medicine.

News of USC's sixth CIRM award announced in recent weeks comes as two more stem cell researchers are headed for the USC campus, continuing the university's a
'"/>

Contact: Jennifer Chan
chanj@usc.edu
323-442-2830
University of Southern California
16-Mar-2007


Page: 1 2 3

Related medicine news :

1. Rutgers professor Bart Krekelberg is named 1 of 20 US Pew Scholars for 2007
2. USC law professor battles schizophrenia
3. Decorated professor adds Farfel Award to his long list of honors
4. Honor for University of Nottingham professor
5. Carnegie Mellon professors question advice for nuclear attacks
6. 2 Rutgers College of Nursing professors study patients with prostate cancer
7. Leader of the pack: Dog groomer turned UH pharmacy professor honored
8. Conference honoring UH professor attracts researchers from United States, abroad
9. Tobacco companies obstructed science, history professor says
10. Picture this: FSU professors research could lead to vastly improved medical imaging
11. Law professor finds home health-care workers have few legal protections

Post Your Comments:
(Date:5/23/2013)... children and adolescents with seizures involving the temporal ... problems and psychiatric illness, especially depression. Findings published ... Wiley on behalf of the International League Against ... evaluation for pediatric epilepsy patientsparticularly for those who ... epilepsy surgery. , Current medical evidence indicates ...
(Date:5/23/2013)... 23, 2013 CareAnyware , ... health and hospice software solutions, and Cornell University ... showed significant reductions in rehospitalization rates for clinically ... Carepath protocol incorporated into CareAnyware’s EMR system. Based ... which included a 39% reduction in rehospitalization rates ...
(Date:5/23/2013)... Lotus Valve, a second-generation transcatheter aortic valve implantation ... the first 60 patients in results from REPRISE ... device performance and low mortality at 30 days., ... but there are opportunities for improvement," explained lead ... and Professor of Medicine, Monash University, Melbourne, Australia. ...
(Date:5/23/2013)... Diego, CA (PRWEB) May 23, 2013 ... Medicus Ltd. (ASX: PME), announced today that they ... available on the Apple App Store*. When used in ... Platform, Visage Ease provides authorized healthcare providers simple mobile ... Touch iOS devices. , In addition to numerous enhancements ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
Breaking Medicine News(10 mins):Health News:Depression common among children with temporal lobe epilepsy 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 3Health News:Second-generation TAVI device -- Lotus Valve -- shows good performance in REPRISE II 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:How to Stay Healthy While Traveling 2
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation ... its Investigational New Drug Application (IND) to evaluate ... the U.S. Food and Drug Administration (FDA). OMS824 ... in areas of the brain linked to a ... Huntington,s disease and schizophrenia. OMS824 has shown promising ...
(Date:5/23/2013)... YORK , May 23, 2013  Echo Pharma ... committed to waive down the Acceptance Threshold from 90 ... plus one Elan Share in accordance with the terms ... the conditions summarized below. Under the terms ... acquire Elan (NYSE: ELN ) for $12.50 ...
(Date:5/23/2013)... CHERTSEY , Engeland, May 23, 2013 ... goed voor mannen met lagere urinewegsymptomen geassocieerd met BPH ... BV, de Europese dochteronderneming van Astellas Pharma Inc, gebaseerd ... : 4503), kondigde vandaag aan dat het Nederlandse ... verleend voor VESOMNI in Nederland. De handelsvergunning ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: